/
/
/

Jenburkt Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)1,022.60
Volume (₹)151.00
High (₹)1,037.80
Upper Circuit1,248.05
Low (₹)1,022.60
Lower Circuit832.05
Prev Close1,040.05
52W High (₹)1,321.00
Price1,037.80
52W Low (₹)944.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)459.00 Cr
Div. Yield (%)1.99
PE Ratio13.98
Debt to Equity0.00
Price to Book2.14
Book Value446.47
EPS (TTM)74.39
Face Value10.00
ROE (%)18.84

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
JENBURPH-BNSE
LTP
1W Low
1W High
Market cap (₹)
1901.45-18.65 (-0.97%)
1900.10
1964.85
4,56,833Cr
9179.5-89.5 (-0.97%)
9051.85
9296
2,45,426Cr
4862.9-172.1 (-3.42%)
4855.90
5049
1,87,320Cr
1131.6-55.4 (-4.67%)
1126
1191.45
1,13,217Cr
1381.2-36.8 (-2.60%)
1377
1426.20
1,12,212Cr
1853.3-82 (-4.24%)
1812
1947.90
1,01,155Cr
2123-52 (-2.39%)
2117.80
2209
97,626Cr
2335.25-52.15 (-2.18%)
2323.15
2407.40
96,859Cr
1161.15-16.65 (-1.41%)
1155
1179.90
96,406Cr
1658+8 (0.48%)
1623.05
1706.70
93,614Cr
1037.8-15.2 (-1.44%)
1022.60
1088.95
459Cr

Key Highlights of Jenburkt Pharmaceuticals Ltd Balance Sheet

Jenburkt Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹4.41Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹4.41Cr, and the reserves and surplus of the company is ₹192.63Cr.

The company has its non-current liabilities with total liabilities of ₹223.61Cr as of 2026-03-31.

The current liabilities are ₹23.15Cr as of 2026-03-31. At the same time, current assets are ₹95.09Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹27.02Cr and tangible assets of ₹19.46Cr, provided in the Jenburkt Pharmaceuticals Ltd financial statements.